Board of Trustees
The Board of Trustees of the Max Planck Institute for Molecular Genetics supports the Institute and fosters connections between the MPIMG and the public. The members of the Board of Trustees are appointed by the president of the Max Planck Society. They meet regularly at the Institute to stay informed about its work and general development. The Board of Trustees is formed by representatives from the local politics, industry, science, and the media.
Prof. Dr. Christopher Baum
Chief Translational Research Officer of Charité – Universitätsmedizin Berlin, Chairman of the Board of Directors of the BIH at CharitéMember of the Board of Trustees for the MPIMG since 2022
Prof. Dr. Angelika Eggert
Director Department of Pediatric Oncology and HematologyDr. Holger Eickhoff
Founder of Scienion GmbHProf. Dr. Elisabeth Gräb-Schmidt
Senior Professor for Systematic Theology at University of Tübingen, Member of the German Ethics CouncilSascha Karberg
Head of the Knowledge & Research Department at the Berliner TagesspiegelDr. Christian Lenz
Vice President Medical Lead GermanyProf. Dr. Max Löhning
Director Pitzer Lab Osteoarthritis Research, Chairman of the Schering FoundationMichael Müller
Member of the national parliament of the Federal Republic of GermanyChristian Rommel
Head of Bayer Pharma Research & DevelopmentMaren Schellenberg
Mayor of the district Berlin Steglitz ZehlendorfChristian Schultz
Director Bethmann Bank ABN AMRO Bank N.V.. Frankfurt BranchJoachim Spranger
Dean of Charité - Universitätsmedizin BerlinProf. Dr. Ariel Dora Stern
Humboldt ProfessorMember of the Board of Trustees for the MPIMG since 2024